Brooks Laboratories Limited(IN:BROOKS)
₹67.43+1.17 (+1.77%)
IN:BROOKS
Brooks Laboratories Limited financials statements
₹67.43
At close:+1.17 (+1.77%)
Want to see IN:BROOKS full AI Analyst Report?
Brooks Laboratories Limited (BROOKS) Financial Statements
2 Followers
Brooks Laboratories Limited Financial Overview
Brooks Laboratories Limited's market cap is currently ₹1.95B. The company's EPS TTM is ₹4.49; its P/E ratio is 2.71; Brooks Laboratories Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 857.38M | ₹ 825.57M | ₹ 794.86M | ₹ 624.80M | ₹ 911.85M |
| Gross Profit | ₹ 179.65M | ₹ 139.22M | ₹ 225.13M | ₹ 126.02M | ₹ -79.11M |
| Operating Income | ₹ 54.70M | ₹ 33.37M | ₹ 11.99M | ₹ -68.98M | ₹ 77.38M |
| EBITDA | ₹ 270.09M | ₹ 58.22M | ₹ 41.73M | ₹ -291.68M | ₹ -134.50M |
| Net Income | ₹ 245.84M | ₹ -99.67M | ₹ -195.92M | ₹ -209.00M | ₹ -193.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 75.49M | ₹ 12.48M | ₹ 1.25M | ₹ 232.00K | ₹ 26.05M |
| Total Assets | ₹ 1.48B | ₹ 1.24B | ₹ 904.45M | ₹ 1.10B | ₹ 1.96B |
| Total Debt | ₹ 85.17M | ₹ 75.83M | ₹ 56.42M | ₹ 65.12M | ₹ 252.59M |
| Net Debt | ₹ 9.68M | ₹ 63.35M | ₹ 55.16M | ₹ 64.89M | ₹ 226.53M |
| Total Liabilities | ₹ 255.17M | ₹ 255.90M | ₹ 248.60M | ₹ 356.44M | ₹ 615.91M |
| Stockholders' Equity | ₹ 1.23B | ₹ 981.04M | ₹ 655.85M | ₹ 739.53M | ₹ 874.90M |
| Cash Flow | |||||
| Free Cash Flow | ₹ 50.87M | ₹ -971.00K | ₹ -101.20M | ₹ -149.58M | ₹ -650.53M |
| Operating Cash Flow | ₹ 85.92M | ₹ 17.62M | ₹ -96.81M | ₹ -144.91M | ₹ -374.41M |
| Investing Cash Flow | ₹ -29.82M | ₹ -460.41M | ₹ 1.82M | ₹ 4.95M | ₹ -249.09M |
| Financing Cash Flow | ₹ 9.34M | ₹ 441.96M | ₹ 96.01M | ₹ 114.14M | ₹ 640.71M |
Currency in INR
